Tag: dihydroergotamine

February 8, 2026 / Mohammed looti

DIHYDROERGOTAMINE

Overview and Historical Context Dihydroergotamine (DHE) is a potent pharmacological agent belonging to the class of ergot alkaloids, primarily indicated for the acute management of migraine headaches. Developed as an improvement upon its precursor, ergotamine tartrate, DHE is chemically derived through the hydrogenation of the double bond in the lysergic acid moiety. This structural modification […]

November 24, 2025 / Mohammed looti

DHE 45

Introduction to DHE 45 and Dihydroergotamine The proprietary designation DHE 45 serves as a well-established trade name for the pharmaceutical compound dihydroergotamine, a semi-synthetic derivative belonging to the ergot alkaloid family. This pharmacological agent is primarily recognized and utilized in the field of neurology for the acute treatment of moderate to severe migraine headaches, often […]